Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 74.56B | 75.01B | 73.58B | 70.27B | 66.63B | 58.54B |
Gross Profit | 33.90B | 34.38B | 32.83B | 32.07B | 31.33B | 28.36B |
EBITDA | 14.52B | 15.80B | 15.02B | 14.85B | 15.33B | 14.29B |
Net Income | -40.55B | 9.12B | -40.79B | 8.18B | 6.85B | 6.03B |
Balance Sheet | ||||||
Total Assets | 125.42B | 113.33B | 111.83B | 115.34B | 126.38B | 118.82B |
Cash, Cash Equivalents and Short-Term Investments | 6.13B | 11.60B | 15.62B | 8.16B | 8.34B | 8.09B |
Total Debt | 25.89B | 38.14B | 39.10B | 28.65B | 28.92B | 30.25B |
Total Liabilities | 78.73B | 82.72B | 86.08B | 80.62B | 77.63B | 75.45B |
Stockholders Equity | 44.21B | 27.77B | 23.23B | 31.90B | 43.94B | 39.31B |
Cash Flow | ||||||
Free Cash Flow | 6.66B | 6.28B | 7.36B | 8.93B | 9.04B | 6.53B |
Operating Cash Flow | 11.39B | 11.31B | 11.61B | 12.95B | 13.26B | 10.93B |
Investing Cash Flow | -8.45B | -1.52B | -6.73B | -3.06B | -4.38B | -5.87B |
Financing Cash Flow | -5.89B | -13.94B | 1.37B | -9.96B | -8.95B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $18.91B | 18.97 | 27.24% | 0.39% | 1.83% | ― | |
79 Outperform | $136.53B | 23.50 | 7.31% | 1.55% | 0.58% | 9.94% | |
75 Outperform | $38.76B | 14.72 | 15.09% | 3.64% | 1.25% | -13.02% | |
73 Outperform | $2.45B | 14.12 | 11.33% | 3.25% | 6.18% | 61.39% | |
65 Neutral | $27.02B | 15.16 | -4.24% | 3.17% | 1.01% | 1.94% | |
65 Neutral | $30.03B | 49.10 | -5.05% | 2.39% | -0.47% | -117.62% | |
65 Neutral | $10.02B | 9.93 | 7.90% | 3.81% | -5.17% | -0.74% |